Related Experiment Videos
Alteration of macrophage responsiveness to platelet-activating factor by interferon-gamma and lipopolysaccharide
1Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis 95616-8643, USA.
Abstract:
Platelet-activating factor (PAF) can modulate several macrophage responses associated with tumoricidal and inflammatory activity. To determine how macrophage responsiveness to PAF may be altered by interferon-gamma (IFN-gamma) or lipopolysaccharide (LPS), we studied PAF receptor-associated activities. Pretreatment of murine peritoneal macrophages with either LPS or IFN-gamma suppressed macrophage responsiveness to both PAF-induced calcium mobilization and superoxide anion (O2-) production. This suppression of macrophage responsiveness to PAF was maximal when 25 U/ml IFN-gamma or 100 ng/ml LPS was initially added for 6 hr. Macrophages pretreated with LPS or IFN-gamma remained refractory to PAF-induced rise in intracellular calcium for 4 to 24 hr. Macrophages preincubated with 25 U/ml IFN-gamma remained refractory to PAF-induced calcium mobilization for up to 4 hr. LPS and IFN-gamma treatment also decreased PAF-induced, calcium-dependent O2- production. When added together, IFN-gamma increased the suppression of PAF-induced intracellular calcium mobilization and inhibited O2- production mediated by LPS. To assess whether suppression was mediated through altered PAF receptors, binding affinities were determined; two binding affinities were demonstrated. Initial incubation of macrophages with LPS or IFN-gamma added alone or together decreased the number of cell surface PAF receptors and their binding affinity. These studies demonstrated that pretreatment with IFN-gamma and LPS can suppress select PAF-induced macrophage functions. Downregulation of PAF receptor activity may represent a means by which macrophages regulate the capacity and magnitude of some PAF-induced responses.
Insights
Interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS) suppress macrophage responses to platelet-activating factor (PAF). This involves reducing PAF receptor number and binding affinity, impacting inflammatory and tumoricidal activities.
Area of Science:
- Immunology
- Cell Biology
- Inflammation Research
Background:
- Platelet-activating factor (PAF) influences macrophage functions critical for tumoricidal and inflammatory activities.
- Understanding how immune modulators affect PAF signaling in macrophages is crucial for immune response regulation.
Purpose of the Study:
- To investigate the impact of interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS) on macrophage responsiveness to PAF.
- To elucidate the mechanisms underlying altered PAF receptor activity following IFN-gamma or LPS pretreatment.
Main Methods:
- Murine peritoneal macrophages were pretreated with varying concentrations of IFN-gamma or LPS.
- PAF-induced calcium mobilization and superoxide anion (O2-) production were measured.
- PAF receptor binding affinities and cell surface receptor numbers were determined.
Main Results:
- IFN-gamma and LPS pretreatment suppressed PAF-induced calcium mobilization and O2- production in macrophages.
- Suppression was dose- and time-dependent, with maximal effects observed after 6 hours.
- Both IFN-gamma and LPS decreased the number and binding affinity of cell surface PAF receptors.
- Combined IFN-gamma and LPS treatment enhanced suppression of calcium mobilization and inhibited O2- production.
Conclusions:
- IFN-gamma and LPS significantly suppress key PAF-mediated macrophage functions.
- Downregulation of PAF receptor number and affinity is a likely mechanism for this suppression.
- These findings suggest a regulatory role for IFN-gamma and LPS in modulating macrophage responses to PAF.